http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2607527-C2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_146c193e5ddbf78ec4e28994d4b83805 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2292 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
filingDate | 2015-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2017-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7b19d780d59b7493e8b00123f136062 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f59132be4b526e5ec7f0ed924dd9ce48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80ae4d0ece8e7fe5c338d4ab7d39287c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ddb8f1097e2b1d240d7c7c2fb2c8a0b |
publicationDate | 2017-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2607527-C2 |
titleOfInvention | Covalent monoconjugate of polyethylene glycol with thymosin beta 4, resistant to degradation in bloodstream and method for its production |
abstract | FIELD: biotechnology. n SUBSTANCE: group of inventions relates to biotechnology and can be used in medicine and pharmaceutical industry. Method for regioselective chemical N-terminal PEGylation of thymosin beta 4. By this method monoconjugate of PEG with thymosin beta 4 is obtained, having improved pharmacokinetic properties. Modification of N-terminal alpha amino group of thymosin beta 4 is confirmed. n EFFECT: use of invention enables to obtain monoPEGylated thymosin beta 4 with high output. n 2 cl, 4 dwg, 3 ex |
priorityDate | 2015-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.